At a glance
Side-by-side comparison
| Metric |
SMLL
BetaShares Australian Small Companies Select ETF
|
SSO
State Street SPDR S&P/ASX Small Ordinaries ETF
|
|---|---|---|
| Snapshot | ||
| Provider |
BetaShares
|
State Street
|
| Tracks index |
Nasdaq Australia Small Cap Select Index
|
S&P/ASX Small Ordinaries Index
|
| Categories |
AU, Small-Cap, Factor, Quality
|
AU, Small-Cap
|
| Listed since |
2017 (9 yrs)
|
—
|
| Fund size (AUM) |
—
|
$25m
|
| Cost & income | ||
| Management fee |
0.39%
|
0.5%
|
| Dividend yield |
—
|
9.5%
|
| Franking |
70%
|
50%
|
| Turnover |
35%
|
20%
|
| Tax drag | 0.84% | 2.14% |
| Returns |
Tax bracket
|
|
| 1-year return |
—
|
1.1%
net
|
| 3-year return |
—
|
6.6%
net
|
| 5-year return |
—
|
1.7%
net
|
| 10-year return |
—
|
5.4%
net
|
| Risk | ||
| Volatility (3y) |
—
|
13.9%
|
| Volatility (5y) |
—
|
16.4%
|
| Volatility (10y) |
—
|
16.7%
|
| Sharpe ratio (3y) |
—
|
0.24
|
| Sharpe ratio (5y) |
—
|
0.11
|
| Sharpe ratio (10y) |
—
|
0.27
|
| Bid/ask spread |
—
|
—
|
marks the strongest fund in each row. “net” shows the after-tax return at your selected bracket. “—” means we don’t have that data point yet.
Each fund at a glance
- Low-cost: a 0.39% management fee keeps more of the return in your pocket.
- Pricier than similar ETFs, which average around 0.34%.
- High 9.5% income yield — good for investors who want regular cash flow.
- Has lagged most peers over 5 years (150th of 188).
Frequently Asked Questions
SMLL and SSO are 2 Australian-listed ETFs we compare side by side. SMLL carries the lower management fee (0.39%). The table above breaks down fees, returns, income and risk for each.
SMLL has the lower management fee at 0.39% a year, versus SSO 0.5%.
SSO pays the higher at 9.5%. Remember distributions are taxed each year at your marginal rate.
SSO is the larger fund by assets ($25m). Larger funds are typically more liquid and trade on tighter spreads.
Related comparisons
General information only, generated from each fund's published data — not personal financial advice. Past performance is not a reliable indicator of future returns. Consider your own circumstances or seek licensed advice before investing.